Sertaconazole in the treatment of mycoses: From dermatology to gynecology

International Journal of Gynecology and Obstetrics

Volumn 71, Issue SUPPL. 1, 2000, Pages 3-20

  Torres, J ^a   Marquez M ^a   Camps, F ^a  

^a Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

Dermatology; Mycoses; Sertaconazole

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; ECONAZOLE; KETOCONAZOLE; MICONAZOLE; PLACEBO; PYRROLE DERIVATIVE; SERTACONAZOLE; SULCONAZOLE; TERCONAZOLE;

ANTIBIOTIC THERAPY; ANTIFUNGAL ACTIVITY; CLINICAL TRIAL; DERMATOMYCOSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MARKETING; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VAGINA CANDIDIASIS;

EID: 0033665054     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0020-7292(00)00349-0     Document Type: Review

References (37)

1. Therapeutic efficacy and safety of the new antmycotic Sertaconazole in the treatment of Pityriasis versicolor
2. Phase II Study of the therapeutic efficacy and safety of the new antimycotic Sertaconazole in the treatment of superficial mycoses caused by Candida albicans
3. Therapeutic efficacy and safety of the new antimycotic Sertaconazole in the treatment of cutaneous dermatophytosis
4. Multi-centre double-blind trial on the efficacy and safety of Sertaconazole 2% cream in comparison with Miconazole 2% cream on patients suffering from cutaneous mycoses
5. Ensayo clnico en fase III de sertaconazol en solucion frente a placebo en el tratamiento de la pitiriasis versicolor
6. Sertazonazol en la dermatitis seborreica del cuero cabelludo
7. Epidemiology of vaginitis
8. Vulvovaginitis candidiasica
9. Evolving pathogens in vulvovaginal candidiasis: Implication for patient care
10. Drugs for treatment of vulvovaginal candidiasis: Comparative efficacy of agents and regimens
11. Management of persistent vulvovaginal candidoses due to azole-resistant C. glabrata
12. In vivo activity of sertaconazole in experimental candidiasis in the mouse
13. Systemic absorption of miconazole from the vagina
14. Untersuchungen zur vaginalen resorption von econazol
15. Evaluacion del riesgo terapeutico
16. Vulvovaginitis: The role of patient compliance in treatment success
17. Efficacy of single vs multiple dose clotrimazole therapy in the management of vulvovaginal candidiasis
18. Treatment of vaginal candidosis with a single 500 mg clotrimazole pessary
19. Vaginal secretion levels after 6 days and 1 day of treatment with 100, 200 and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy
20. Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison
21. Treatment options for vulvovaginal candidiasis 1993
22. Evaluation of new anti-infective drugs for the treatment of vaginal infections
23. Terapeutica de las micosis superficiales
24. Stevens-Johnson syndrome after fluconazole
25. Angio-oedema after fluconazole
26. Hepatic injury associated with itraconazole
27. Vaginal infections in adult women
28. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis
29. Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo
30. Therapeutic results obtained in vaginal mycoses after singel-dose treatment with 500 mg clotrimazole vaginal tablets
31. One-dose therapy of Candida vaginitis. I. Results of an open multicentre trial
32. Efficacy and tolerability of singel-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole
33. A dose-response study with Monistat cream
34. Terconazole for the treatment of vulvovaginal candidiasis